#AI can accelerate drug discovery, but can it increase the probability of success? . In this new Drug Discovery Today article, TARA CEO @mistiushio & @vant_ai CEO Zach Carpenter discuss ways to better translate AI-enabled candidates to humans: .

It’s official. We’re proud to announce that TARA has been acquired by @ValoHealth. This deal gives Valo exclusive access to our proprietary human #CardiacDisease models, which it will leverage to advance #DrugDiscovery for cardiovascular disease.

TARA's own Nicole Feric is on the ground at @SOToxicology presenting a joint poster with @Sanofi. It highlights the sensitivity of TARA’s 3D tissues over 2D cells when predicting cardiac inotropic response in a study comparing 25 reference compounds. Stop by to learn more!.

Thanks to @GENbio for featuring TARA in their article "Opening new lines of attack against cardiovascular disease." We're in good company with @VerveTx, @TenayaThera, @BridgeBioPharma, and Maze Therapeutics also highlighted.

TARA in the @WSJ today! . Newly launched VC firm, and TARA investor, @OmxVentures aims to raise $250 Million for Latest Life-Sciences Fund and back 25 start-ups by year-end. #lifesciences #funding #startups .

3D cell cultures are rapidly replacing conventional tissue cultures - & even some animal test models in biology & medicine. Through the lens of #cardiacfunction modeling advancements, our CEO @MistiUshio sheds some light with @biocompare .

A convergence of technology breakthroughs has opened the door to precise molecular targeting and personalization. With these genetically defined subpopulations, we can develop drugs that address the true underlying cause of #cardiac diseases. Learn more:

Learn how we engineer human heart biology and build predictive data sets that can increase the probability of success and shorten the expensive path of #cardiac drug development. #heartdisease #drugdiscovery .

Remarkable progress in three converging fields has transformed how we define, study, and treat #cardiac diseases. 1. Biomedical science.2. Tissue engineering.3. Stem cell technology. Learn more in our new drug discovery whitepaper:

RT @DDWJournal: @tarabio, a biotechnology company using human biology and data for cardiac drug discovery, has collaborated with @ScipherMe….

Interest in cardiac #DrugDiscovery and development is surging as more and more hurdles are overcome. In this whitepaper, we explore the tools and tactics fueling this new era in precision cardiac medicine. Download the whitepaper here:

Today we've announced an exciting #partnership with @ScipherMedicine aimed to address a critical unmet need for effective therapeutics in cardiac laminopathies. Together, we’re on track to reduce target discovery and validation from years down to months.

Animal testing has never been ideal from an ethical and scientific standpoint. In this latest episode of @AfterAnimalsPod, TARA CEO @mistiushio discusses how TARA's tech could reduce pharma's reliance on #animaltesting without compromising human safety.

Nice piece on the future of #drugdiscovery using organ-on-a-chip technology to replace #animaltesing. “Organ-on-a-chip is not just one workflow point in time,” @mistiushio says. “You can use it along an entire drug discovery and development continuum.”.

Gordana is a finalist for the 2021 European Inventor Award, one of Europe's most prestigious innovation prizes sponsored by the @EPOorg. Congrats @GVNlab !! Go vote !!.

RT @organoidscience: ✨ New in @NatureProtocols!. Milica Radisic (@milicaruoft) & @bme_uoft researchers describe a method to cultivate milli….

RT @ColumbiaBME: We are beyond proud of @Columbia University Professor/@ColumbiaMed/@ColumbiaBME Professor Gordana Vunjak-Novakovic @GVNlab….

#HeartiFact: TARA leverages our groundbreaking stem cell & tissue engineering platform to generate functioning human heart tissue & human-relevant data, increasing the probability of success for cardiac drug discovery & development. Learn more here:

#HeartiFact: we are already seeing exciting news in the cardiac space in 2021 with the approval of @Merck & @BayerUS's Verquvo for patients with chronic heart failure. Check out major trends in cardiac drug discovery in 2020 in this @Tech_Networks piece:

Check out the @NYCHBL 2021 Healthcare Innovation Report for thoughts from our CEO @mistiushio on TARA's efforts to leverage our human-relevant datasets for cardiac drug discovery and improve efficiencies during and following the COVID lockdown in NYC: .